Epalex
MOUNTAIN VIEW, CA · Healthcare, Health Care · 50 employees
EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. When a seizure warning sign (aura) occurs, the patient will be able to prevent the development of a full-blown seizure through the use of a pocket nebulizer to deliver a powerful antiseizure medication that rapidly
Funding history
- Funding Round — $1.2M — Nov 2025
- Series seed — $4.0M — Dec 2024
- Series seed — $4.3M — Oct 2022
- Funding Round — $20.3M — Dec 2020
- Funding Round — $20.3M — Jan 2019
Recent signals
- Nov 10, 2025: Raised $1.2M
- Dec 20, 2024: Raised $4.0M in Series seed
- Oct 14, 2022: Raised $4.3M in Series seed
- Dec 18, 2020: Raised $20.3M
- Jan 10, 2019: Raised $20.3M
See plans & pricing → Track Epalex ’s funding, hiring, and signals — with verified contacts — on Fundz.